Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2006, p. 2666-2668, Vol. 44, No. 7
0095-1137/06/$08.00+0 doi:10.1128/JCM.00274-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |
Infectious Diseases Service,1 Pneumology Service,2 Laboratory of Microbiology, Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul,3 Microbiology Service, Hospital Mãe de Deus,4 Nephrology Unit, Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil5
Received 7 February 2006/ Returned for modification 26 April 2006/ Accepted 1 May 2006
|
|
|---|
|
|
|---|
![]() View larger version (112K): [in a new window] |
FIG. 1. Chest X-ray image showing a right lower lobe opacity.
|
![]() View larger version (71K): [in a new window] |
FIG. 2. Cavitary lesion at the anterior and lateral basal segments transition of the right lower lung lobe on chest X-ray (A) and computed tomographic (B) images.
|
A transthoracic pulmonary fine-needle aspiration was performed, and approximately 1 ml of nonfetid purulent secretion was obtained. The Gram stain showed intracellular, gram-negative diplococci and many polymorphonuclear leukocytes. The sample was inoculated onto chocolate agar and 5% sheep blood agar (bioMérieux, Brazil). The agar media were incubated at 36°C for 48 h. Opaque, oxidase-positive colonies that looked like gram-negative cocci were observed. The panel HNID (Dade Behring, Inc., West Sacramento, CA) was used according to the manufacturer's protocol. The following tests were performed: indoxyl-phosphatase, nitrate, nitrite, glucose, sucrose, maltose, fructose, lactose, urea, ornithine, indole, L-prolyl-ß-naphtylamide, N-
-L-glutamil-ß-naphtylamide, N-
-benzoyl-DL-arginine, ß-naphtylamide, p-nitrophenil-
-D-glucoside, starch, and o-nitrophenil-ß-D-galactoside. The tests with a positive result included glucose, maltose, lactose, o-nitrophenil-ß-D-galactoside, and L-prolyl-ß-naphtylamide. The organism was identified as Neisseria lactamica with 99.9% probability. A chromogenic cephalosporin test, with nitrocefin (Becton Dickinson, Sparks, MD), was performed to check the organism's ability to produce ß-lactamase, and the result was negative.
Cephalosporin (acetyl cefuroxime) treatment was then started, with immediate resolution of the symptoms and with partial regression of the cavity after 1 month of treatment. Oral ciprofloxacin replaced acetyl cefuroxime after 3 months. A 5-month follow-up revealed an almost complete resolution of the lesion, and ciprofloxacin therapy was then stopped.
We describe here a case of N. lactamica infection that likely began as a partially treated pneumonia and then asymptomatically evolved over 6 months to a cavitary lung lesion. To our knowledge, only one other case of N. lactamica infection in an adult patient has been reported (3). It occurred in a 46-year-old woman who developed meningitis caused by a nasal cerebral spinal fluid leak after skull trauma (3). Although another case in an 18-year-old female patient with vaginal discharge has been reported, the role of N. lactamica as an etiologic agent of the vaginitis was not certain (12). The present case is the first report of N. lactamica causing pulmonary infection and the second report of an N. lactamica infection in an adult patient.
N. lactamica is a harmless human commensal organism closely related to N. meningitidis and N. gonorrhoeae, both pathogens of global significance (1). Infection by this organism is an extremely rare entity, although a few cases have been reported, most of them in infants and newborns (2, 3, 5, 6, 8, 10-12, 14) (Table 1). This may be explained by the fact that N. lactamica carriage throughout the world is high in infants and young children and declines with age (4).
|
View this table: [in a new window] |
TABLE 1. Infections by Neisseria lactamica reported in the literature
|
Treatments of previous cases of N. lactamica infections were usually short, and all patients were cured (Table 1). Our patient was treated for a longer time, since the length of the therapy was based on the radiological resolution of the cavitary lesion, although the infection had possibly been resolved earlier.
Neisseria spp. may be differentiated by their patterns of acid production from glucose, maltose, lactose, sucrose, and fructose. The most prominent biochemical feature of the species is the production of acid from lactose, which distinguishes N. lactamica from all other species of the genus (1). The HNID panel is a microdilution tray system that uses chromogenic enzyme substrates and modified conventional tests for the identification of Neisseria spp., Haemophilus spp., and Moraxella spp. These tests provide a reaction profile that allows immediate differentiation among the groups of Neisseria spp. (7). Although in vitro susceptibility testing is recommended for any gram-negative, oxidase-positive diplococcus isolated from clinically relevant specimens (7), the Clinical and Laboratory Standards Institute does not provide interpretive criteria for testing members of the genus Neisseria other than N. gonorrhoeae and N. meningitidis. Thus, we performed the direct nitrocefin-based ß-lactamase test, which detects ß-lactamase-mediated penicillin resistance (7).
Thus far, the clinical relevance of N. lactamica has been limited to the fact that, like other Neisseria species, this organism can transfer antibiotic resistance markers into the closely related species N. meningitidis (9). However, although still extremely rare, N. lactamica may be important as a human pathogen, particularly in immunocompromised patients. A better understanding of a possible relationship between immunosuppression, nasopharyngeal colonization, and invasive disease may determine the real importance of N. lactamica as an adult human pathogen.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»